Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

PURPOSE: A new tool based on clinical characteristics and molecular factors (Lung-molGPA) was developed to predict the survival of patients with non-small-cell lung cancer but was has not been validated. This study aims to validate the feasibility of the Lung-molGPA in NSCLC. PATIENTS AND METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ji, Jing, Wang, Zhai, Xiaoyang, Jia, Wenxiao, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936709/
https://www.ncbi.nlm.nih.gov/pubmed/33688209
http://dx.doi.org/10.2147/OTT.S288928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936709/
https://www.ncbi.nlm.nih.gov/pubmed/33688209
http://dx.doi.org/10.2147/OTT.S288928

Ejemplares similares